feed,title,long_url,short_url
SeekingAlpha,GSK's Nucala OK'd in Europe for three additional eosinophil-driven diseases,https://seekingalpha.com/news/3771767,
SeekingAlpha,"Target EPS beats by $0.23, beats on revenue",https://seekingalpha.com/news/3771766,
